Inflammatory mechanisms in major depressive disorder

@article{Raedler2011InflammatoryMI,
  title={Inflammatory mechanisms in major depressive disorder},
  author={Thomas J. Raedler},
  journal={Current Opinion in Psychiatry},
  year={2011},
  volume={24},
  pages={519–525}
}
  • T. Raedler
  • Published 1 November 2011
  • Psychology, Biology
  • Current Opinion in Psychiatry
Purpose of review As the ‘monoamine hypothesis of depression’ fails to explain all aspects of major depression, additional causes are being investigated. Several observations suggest that inflammatory mechanisms pay a role in the cause of major depressive disorder (MDD). This article reviews their role in major depression. Recent findings Recent studies support the concept that inflammatory mechanisms play a crucial role in the pathomechanisms of major depression. Major depression shares… 
Insights into Macrophage Heterogeneity and Cytokine-Induced Neuroinflammation in Major Depressive Disorder
TLDR
The field of inflammasome-mediated neuroinflammation is an emerging area of MDD research that is providing new cellular insight into how macrophages mechanistically support cytokine-associated neuropathology, particularly in the case of IL-1β-associated inflammation in MDD.
Effects of Antidepressant Treatment on Peripheral Biomarkers in Patients with Major Depressive Disorder (MDD)
TLDR
Emergent evidence indicates that MDD is related to disturbed neurogenesis and suggests a possible role of neurotrophic factors in recovery of function in patients, and emerging data regarding the influence of different antidepressant drugs on a wide array of peripheral biomarkers such as interleukin (IL-1ß), IL-2, IL-5, ILs, or interferon (IFN)-γ are outlined.
Neutrophil–lymphocyte ratio in patients with major depressive disorder undergoing no pharmacological therapy
TLDR
The findings of the study reveal that NLR tends to be higher in patients with MDD, and a high NLR value supports the view that inflammation is a critical factor in the etiology of MDD.
The role of inflammatory cytokines on the aetiopathogenesis of depression
TLDR
There is a growing body of correlative studies that suggest inflammatory cytokines may be a central factor that can affect multiple neuronal pathways and have an additive effect on the development of depression.
Alterations of multiple peripheral inflammatory cytokine levels after repeated ketamine infusions in major depressive disorder
TLDR
The results suggest that the inflammatory pathway may be involved in the antidepressant effects of ketamine, which may be conducive to future treatment strategy optimization.
Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression
TLDR
It is confirmed that chronic forms of the two major subtypes of depression are associated with different biological correlates with inflammatory and metabolic dysregulation in atypical depression and HPA-axis hyperactivity in melancholic depression.
Effects of Antidepressant Treatment on Neurotrophic Factors (BDNF and IGF-1) in Patients with Major Depressive Disorder (MDD)
TLDR
Data on the effects of various antidepressants on serum levels of neurotrophins such as brain-derived neurotrophic factor (BDNF) and insulin-like growth factor (IGF-1) suggest BDNF as a promising predictor of treatment response in MDD patients and preliminary data suggest IGF-1 needs further investigation.
Inflammation as the common biological link between depression and cardiovascular diseases: Can carnosine exert a protective role?
TLDR
The role of oxidative stress and chronic inflammation as common pathophysiological events both in depression and CVD and the preclinical and clinical evidence on the protective effect of carnosine in both diseases as well as the therapeutic potential of this dipeptide in depressed patients with a high co-morbidity of cardiovascular diseases are discussed.
Accelerated Aging in Major Depression: The Role of Nitro-Oxidative Stress
TLDR
Nitro-oxidative stress plays a fundamental role in aging, as well as in the pathogenesis of neurodegenerative disorders, and major depression, and common therapeutic tools could be investigated for the prevention and treatment of these disorders.
...
...

References

SHOWING 1-10 OF 82 REFERENCES
Inflammatory Biomarkers in Depression: An Opportunity for Novel Therapeutic Interventions
TLDR
The inflammatory hypothesis of depression marks a significant shift away from monoamine-based approaches and is a major step towards developing novel treatments that directly target causal factors of depression.
Understanding the role of inflammatory-related pathways in the pathophysiology and treatment of psychiatric disorders: evidence from human peripheral studies and CNS studies.
  • B. Dean
  • Psychology, Medicine
    The international journal of neuropsychopharmacology
  • 2011
TLDR
Data suggesting that acute-reactive proteins and cytokines are affected by the pathophysiology of mood disorders and schizophrenia, that levels of blood inflammation-related proteins before and after treatment might be useful in the diagnosis of psychiatric disorders or measuring responsiveness to drug treatment are focused on.
The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression
TLDR
A hypothesis integrating current concepts of neurotransmission and hypothalamus–pituitary–adrenal (HPA) axis dysregulation with findings on immunological alterations and alterations in brain morphology in MD is presented.
The Effect of Newer Serotonin-Noradrenalin Antidepressants on Cytokine Production: A Review of the Current Literature
TLDR
The results of the present review support the notion that the serotonin-noradrenalin antidepressants venlafaxine and mirtazapine may influence cytokine secretion in patients affected by MD, restoring the equilibrium between their physiological and pathological levels and leading to recovery.
Endocrine and immune substrates of depressive symptoms and fatigue in multiple sclerosis patients with comorbid major depression
TLDR
A role for HPA axis hyperactivity in major depression in MS is supported and inflammatory and neuroendocrine factors may differentially mediate fatigue and depressive symptoms.
A Meta-Analysis of Cytokines in Major Depression
Inflammatory Biomarkers and Depression
TLDR
The effects of COX-2 inhibition in the CNS as well as the different components of the inflammatory system, the kynurenine-metabolism and the glutamatergic neurotransmission, however, still need careful further scientific evaluation.
...
...